GABAergic mechanisms in generalized epilepsies: The neuroanatomical dimension;Mecanismes GABAergiques dans les epilepsies generalisees: La dimension neuroanatomique

Revue Neurologique

Volumn 153, Issue SUPPL. 1, 1997, Pages

  Depaulis, A ^a   Deransart, C ^a   Vergnes, M ^a   Marescaux, C ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID;

ABSENCE; AMYGDALOID NUCLEUS; EPILEPTOGENESIS; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; NEUROMODULATION; NONHUMAN; PATHOLOGICAL ANATOMY; RECEPTOR BLOCKING; REVIEW; SUBSTANTIA NIGRA; THALAMOCORTICAL TRACT; THALAMUS; ANIMAL; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; GENERALIZED EPILEPSY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SEIZURE; SYNAPTIC TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; EPILEPSY, GENERALIZED; GAMMA-AMINOBUTYRIC ACID; HUMANS; RATS; SEIZURES; SYNAPTIC TRANSMISSION;

EID: 0002097431     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. ALEXANDER G., CRUTCHER M. (1990). Functional architecture of basal ganglia circuits neural substrates of parallel processing. Trends Neurosci, 13 : 266-271.
2. BRADFORD H.F. (1995). Glutamate, GABA and epilepsy. Prog Neurobiol, 47 : 477-511.
3. CHEVALIER G., VACHER S., DENIAU J., DESBAN M. (1985). Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res, 334 : 215-226.
4. CRUNELLI V., FRICKER D., LE FEUVRE Y., EMRI Z.S., TURNER J.P., WILLIAMS S.R., LERESCHE N. (1996). Presynaptic GABA-B receptors on GABA and glutamate containing afferents in the thalamus. Pharmacol Rev Comm, 8 : 107-110.
5. CRUNELLI V., LERESCHE N. (1991). A role for GABA-B receptor in excitation and inhibition of thalamocortical cells. Trends Neurosci, 14 : 16-21.
6. DEAN P., GALE K. (1989). Anticonvulsant action of GABA receptor blockade in the nigro-collicular target region. Brain Res, 477 : 391-395.
7. DENIAU J.M., MENETREY A., CHARPIER S.(1996). The lamellar organization of the rat substantia nigra pars reticulata : Segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience, 73 : 761-781.
8. DEPAULIS A., LIU Z., VERGNES M., MARESCAUX C., MICHELETTI G., WARTER J. (1990). Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res, 5 : 192-198.
9. DEPAULIS A., VERGNES M., LIU Z., KEMPF E., MARESCAUX C. (1990). Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat. Neuroscience, 39 : 339-349.
10. DEPAULIS A., VERGNES M., MARESCAUX C. (1994). Endogenous control of epilepsy: the nigral inhibitory system. Prog Neurobiol, 42 : 33-52.
11. DERANSART C., MARESCAUX C., DEPAULIS A. (1996). Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat. Neurosci, 71 : 721-728.
12. FALLON J.H., LOUGHLIN S.E. (1995). Substantia nigra. In : The rat nervous system, Paxinos G, eds. Academic Press, New York : 215-238.
13. GALE K. (1985). Mechanisms of seizure control mediated by gamma aminobutyric acid: role of the substantia nigra. Fed Proc, 44 : 2414-2424.
14. GARANT D.S., GALE K. (1987). Substantia nigra-mediated anticonvulsivant actions: role of nigral output pathways. Exp Neurol, 97 : 143-159.
15. GLOOR P., FARIELLO R.G. (1988). Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci, 11 : 63-68.
16. HALONEN T., NISSINEN J., JANSEN J.A., PITKANEN A. (1996). Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus. Eur J Pharmacol, 299 : 69-81.
17. HOPKINS D.A., NIESSEN L.W. (1976). Substantia nigra projections to the reticular formation, superior colliculus and central gray in the rat, cat and monkey. Neurosci Letters, 2 : 253-259.
18. HOSFORD D.A., LIN F., KRAEMER D.L., CAO Z., WANG Y., WILSON J.T.J. (1995). Neural network of structures in which GABA-B receptors regulate absence seizures in the lethargic (lh :lh) mouse model. J. Neurosci, 15 : 7367-7376.
19. JOHNSTON M.V. (1996). Developmental aspects of epileptogenesis. Epilepsia, 37 : S2-S9.
20. KANDEL A., BRAGIN A., CARPI D., BUZSAKI G. (1996). Lack of hippocampal involvement in a rat model of petit mal epilepsy. Epilepsy Res. 23 : 123-127.
21. LIU Z., VERGNES M., DEPAULIS A., MARESCAUX C. (1991). Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizure in the rat. Brain Res, 545 : 1-7.
22. LIU Z., VERGNES M., DEPAULIS A., MARESCAUX C. (1992). Involvement of intrathalamic GABA neurotransmission in the control of absence seizures in the rat. Neurosci, 48 : 87-93.
23. MARESCAUX C., VERGNES M. (1995). Animal models of absence seizures and absence epilepsies. In: Typical absences and related epileptic syndromes, Duncan JS, Panaviotopoulos CP, eds. Chruchill Communications Europe, Londres : 8-18.
24. MARESCAUX C., VERGNES M., DEPAULIS A. (1992). Genetic absence epilepsy in rats from Strasbourg - A review. J Neural Transm, Suppl 35 : 37-70.
25. MARESCAUX C, VERGNES M, LIU Z, DEPAULIS A, BERNASCONI R (1992). GABAB receptor involvement in the control of genetic absence seizures in rats. In: Molecular neurobiology of epilepsy, Epilepsy Res, Engel J, et al., eds. Elsevier, Amsterdam : 131-139.
26. MARESCAUX C., VERGNES M., MICHELETTI G., DEPAULIS A., REIS J., RUMBACH L., WARTER J., KURTZ D. (1984). Une forme génétique d'absences petit mal chez le rat Wistar. Rev Neurol (Paris), 140 : 63-66.
27. MARESCAUX M., VERGNES M., DEPAULIS A., MOSHE S. (1992). Neurotransmission in rats' spontaneous generalized nonconvulsive epilepsy. In: Neurotransmitters in epilepsy, Epilepsy Res, Avanzini G, Engel J, Fariello R, Heinemann U, eds. Elsevier, Amsterdam : 335-343.
28. MCCORMICK D.A. (1992). Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol, 39 : 337-388.
29. MELDRUM B.S. (1982). Pharmacology of GABA. Clin Neuropharmacol, 5 : 293-316.
30. NIEDERMEYER E. (1996). Primary (idiopathic) generalized epilepsy and underlying mechanisms. Clin Electroencephal, 27 : 1-21.
31. OTTERSEN O.P., HJELLE O.P., OSEN K.K., LAAKE J.H. (1995). Amino Acid Transmitters. In : The rat nervous system, Paxinos G, eds. Academic Press, New York : 1017-1040.
32. PETROFF O.A.C., ROTHMAN D.L., BEHAR K.L., LAMOUREUX D., MATTSON R.H. (1996). The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol, 39 : 95-99.
33. ROBERTS E. (1986), Failure of GABAergic inhibition : a key to local and global seizures. In: Advances in Neurology (vol. 44), Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ, eds. Raven Press, New York : 319-341.
34. SLOVITER R.S., TAMMINGA C.A. (1995). The hippocampus in epilepsy. Am J Psychiatry, 152 : 659.
35. SNEAD O.C. (1996). Antiabsence seizure activity of specific GABA(B) and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav, 53 : 73-79.
36. STEFAN H., PLOUIN P., FISCHSEL H., JALIN C., BURR W. (1988). Progabide for previously untreated absence epilepsy. Epilepsy Res, 2 : 132-136.
37. TURSKI L., MELDRUM B.S., CAVALHEIRO E.A., CALDERAZZO-FILHO L.S., BORTOLOTTO Z.A., IKONOMIDOU-TURSKI C., TURSKI W.A. (1987). Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci USA, 84 : 1689-1693.
38. VERGNES M., MARESCAUX C., DEPAULIS A. (1990). Mapping of spontaneous spike and wave discharges in wistar rats with genetic generalized non convulsive epilepsy. Brain Res, 523 : 87-91.
39. VERGNES M., MARESCAUX C., MICHELETTI G., DEPAULIS A., RUMBACH L., WARTER J. (1984). Enhancement of spike and wave discharges by GABA mimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neurosci Lett, 44 : 91-94.
40. WALKER M.C., SANDER J.W.A.S. (1996). The impact of new antiepileptic drugs on the prognosis of epilepsy: Seizure freedom should be the ultimate goal. Neurology, 46 : 912-914.
41. WYLLIE E., LÜDERS H. (1993). Classification of seizures. In: The treatment of epilepsy: principles and practices, Willie E, eds. Lea & Fibiger, Philadelphia : 359-361.